NSUN2 can be used as a potential prognostic marker for HNSCC, providing a reference for finding new treatments.431 Interestingly, in OC, studies reported for the first time that NSUN2 and insulin-like growth factor-II (IGF-II) synergistically affected patient survival and prognosis. This evidence concerns the gene IGF2 and head and neck squamous cell carcinoma.